openPR Logo
Press release

Global Next Generation Sequencing Market 2019: Global Industry Analysis Report to 2025

01-05-2021 07:34 AM CET | Science & Education

Press release from: Orion Market Research

Global Next Generation Sequencing Market 2019: Global Industry

The global next generation sequencing market is projected to exhibit a significant growth, at a CAGR of around 16.4%, during the forecast period. The increasing adoption of personalized medicines for the treatment of cancer is augmenting the growth of the next generation sequencing technology market. Personalized medicine has the potential to modify therapy with the best response and highest safety margin to ensure better patient care. By enabling these medicines, each patient can receive earlier diagnoses, risk assessments, and optimal treatments. The personalized medicine holds promise for improving healthcare while lowering costs which is expected to be a positive indicator for the growth of the global next generation sequencing market.

Request a Free Sample of our Global Next Generation Sequencing Market:

The personalized medicine is defined as a point of care in the treatment that is customized as per an individual patient. There have been several types of research going on presently to develop personalized medicine based on the patients. Several factors should be considered before providing personalized medicine to a patient. Primarily, the doctors must detect the type of diseases, such as cancer, or the symptoms of it that can be developed in a patient. Detection of cancer is important for the surgeon or the doctor to find the best-suited therapy that can treat the person.

For developing of personalized medicine, several genetic tests need to be taken in account as these tests will eventually reveal the various conditions of the patients such as detection of the individual developing a specific type of cancer. The personalized medicine provides an approach to treat the patient based on the age, sex, type of cancer, the reaction towards a drug and other factors. As per the Personalized Medicine Coalition (PMC) 2017 report, around 42% of all compounds and around 73% of oncology compounds in the pipeline have the potential to be included in personalized medicines.

The biopharmaceutical companies closely doubled their R&D investment in personalized medicine over the past five years and suppose to increase their investment in the near future. The US FDA has received a significant number of personalized medicines for its approval in the past years. As per the US FDA data, the organization has approved around 21% of personalized medicines in 2014, which rammed up to 34% in 2017. These figures reflect the surging demand for personalized medicines across the globe, promising ample opportunities for the next generation sequencing market.

A full Report of Global Next Generation Sequencing Market is Available at:

Global Next Generation Sequencing Market-Segmentation

By Product Type
• Reagents and Kits
• Instruments
• Services

By Technology

• Pyrosequencing
• Sequencing by Synthesis (SBS)
• Sequencing by Ligation (SBL)
• Whole Genome Sequencing
• RNA Sequencing
• Targeted Resequencing
• Others (Methyl Sequencing)

By Application

• Drug Discovery
• Genomic Research
• Disease Diagnostics
• Personalized Medicine
• Others (Agricultural and Animal Research)
By End-User

• Academic and Clinical Research Centers
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CRO)
• Hospitals and Clinics

Global Next Generation Sequencing Market– Segment by Region

North America
• United States
• Canada


• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe


• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World

Company Profiles

• 10x Genomics, Inc.
• Agilent Technologies, Inc.
• Agilent Technologies, Inc.
• Becton, Dickinson and Co.
• BGI Group
• CD Genomics
• CeGaT GmbH
• Charles River Laboratories International, Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Macrogen, Inc.
• Novogene Corp.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California, Inc.
• PerkinElmer Inc.
• Phalanx Biotech Group
• Qiagen N.V.
• Thermo Fisher Scientific, Inc.
• Xcelris Genomics

For More Customized Data, Request for Report Customization @

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Next Generation Sequencing Market 2019: Global Industry Analysis Report to 2025 here

News-ID: 2220560 • Views: 166

More Releases from Orion Market Research

Asia Pacific Calcium Carbonate Market 2020 Growth, COVID Impact, Trends Analysis …
Asia-Pacific calcium carbonate market is estimated to grow at a CAGR of 4.1% during the forecast period. Significant growth in end-user industries such as plastics, paper, and paints and coatings industry is primarily driving the demand for calcium carbonate in the region. China holds the largest share in the plastics manufacturing globally, which is followed by Europe and NAFTA. Plastics manufacturing has also witnessed significant growth in India. For instance,
US Home Gym Equipment Market 2020 Growth, COVID Impact, Trends Analysis Report 2 …
The US home gym equipment market is estimated to exhibit a sturdy CAGR during the forecast period (2020-2026). The sales of home gym equipment have witnessed a recording-breaking surge in the initial months of the COVID-19 pandemic as most of the fitness centers and gyms were closed in compliance with the lockdown regulations. Even before the arrival of COVID-19, the country experienced a surge in the fitness conscious individuals as
Spain Electric Vehicle Charger Market Trends 2019 | Segmentation, Outlook, Indus …
Spain electric vehicle charger market is anticipated to grow at a CAGR of over 20% during the forecast period, 2019-2025. In 2019, the government of Spain announced a target of 100% Zero Emission Vehicle (ZEVs) by 2040. Government subsidies in order to motivate the electric vehicle market are one of the major factors for the growth of the market in the country. The country introduced first subsidies on electric vehicle
European Calcium Carbonate Market Growth, Size, Share and Forecast 2020-2026
European calcium carbonate market is estimated to grow at a CAGR of 2.9% during the forecast period. As per the Confederation of European Paper Industries (CEPI), the pulp and paper industry in Europe generated a turnover of nearly $101 billion in 2019. The production capacity of paper and board in Europe increased from 101.2 million tons in 2018 to 101.5 million tons in 2019. Calcium carbonate is often utilized in

All 5 Releases

More Releases for Sequencing

Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Get Research Sample PDF at Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,
Next Wave in DNA Sequencing Market
Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run. DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno … has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the
Next Generation Sequencing Market By Key Manufacturers (Illumina, Qiagen, Perkin …
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical
Pyro Sequencing Market: Business Intelligence & Market Insights
Pyro sequencing is a DNA sequencing technology based on the principle of sequencing-by-synthesis. The method consist of series of four enzymatic steps to detect sequence of nuclei acid during synthesis. Pyro sequencing can be easily automated and provides highly accurate results. The method is highly suitable for analysis of single nucleotide polymorphism and sequencing of small fragment of DNA. Pyro sequencing techniques consist of series of sequential steps for detection
Next-generation Sequencing Market
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate,